Cycle four of six. The biometric failed. Chemo paused.
🧑⚕️ Diya, 34, worked at a bank in Kolkata. Her mother, Anjali, 61, was diagnosed with stage-IIB breast cancer. Six cycles of chemotherapy, ₹9.8 lakh total cost. Swasthya Sathi card covered it fully. Cycles 1, 2, 3: card worked, biometric scanned green, cashless authorization approved. Cycle 4, mid-March: biometric error. "Cardholder record requires reverification." Hospital treatment paused. Reverification required a trip to Asansol, where her mother had been registered into the scheme in 1971—250 km away, 5-hour drive each way.
🚨 The problem
Biometric systems degrade fingerprints, iris patterns change. When authentication fails mid-treatment, reverification becomes mandatory. But reverification is required at the original registration location, not the treatment location. A patient in the middle of chemotherapy must travel 250 km to reverify. Treatment pauses while bureaucracy catches up.
🚀 How GabFORGE helped
Diya photographed the biometric error at the hospital, the Swasthya Sathi card (registered in Asansol), the chemo cycle schedule, and the BDO office address list.
- 🔍 Found the emergency-reverification rule. Read Swasthya Sathi protocols and discovered: mid-treatment biometric failures have an "emergency-care continuance" clause. Treatment can continue for up to 15 days while reverification is pending if the treating hospital submits a "treatment-critical" request to the state health department.
- 💬 Named the hospital's procedure. Tata Medical Centre's social work office submits a written request to West Bengal Health Department ([email protected]) stating: cancer-treatment cycle in progress, biometric failure not patient's fault, treatment-critical status. Department approves, hospital authorized to continue for 15 days.
- 📞 Provided the emergency contact and form name. Form: "Treatment Critical Continuance Request." Email provided.
Diya contacted Tata Medical Centre's social work office. They submitted the emergency request same day. Approval came within 3 hours. Cycle 4 continued. Reverification happened offline (her mother visited Asansol during treatment break week). Cycles 5 and 6 proceeded without interruption.
🇮🇳 Why this matters
Biometric failures mid-treatment are technical issues, not eligibility issues. Emergency-care provisions exist to prevent treatment delays. But the provisions aren't advertised. Treatment pauses while families scramble to reverify.
The long version has the biometric error mid-cycle, the Asansol requirement, the 250 km reverification trip, and the emergency-care provision that existed but was never offered.